CRCM LP holds a concentrated book of 14 stocks worth $152.2M as of Q2 2026 (disclosed Aug 18, 2026, a ~49-day 13F lag). This quarter they opened Ishares Bitcoin Trust ETF and trimmed Burning Rock Biotech Ltd-ADR. Their largest long position is Ishares Gold Trust at 65% of the equity book. Cloning the disclosed picks since 2025 would be +56% (+32.9%/yr). That is a simulation of the disclosed long book, not audited returns.
Following at the filing date actually beat the quarter-end book by 11.6 points over this window.
Growth of $10,000 cloning CRCM LP's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~49 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
97% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as CRCM LP
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| MORGAN STANLEY | 12 / 14 | $3.6B |
| UBS Group AG | 11 / 14 | $1.9B |
| BANK OF AMERICA CORP /DE/ | 10 / 14 | $3.8B |
| BlackRock, Inc. | 10 / 14 | $1.5B |
| JPMORGAN CHASE & CO | 10 / 14 | $1.3B |
| GOLDMAN SACHS GROUP INC | 10 / 14 | $914.6M |
| MILLENNIUM MANAGEMENT LLC | 10 / 14 | $759.8M |
| Ken Griffin | 10 / 14 | $199.8M |
Ranked by how many of CRCM LP's top 14 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Ishares Gold Trust ETF ISHARES NEW | $99.2M | 1.31M | 65.2% | ▲+5.1% Added · +64K sh | |
| 2 | Ishares Bitcoin Trust ETF SHS BEN INT | $10.1M | 303.6K | 6.6% | ▲New New position | |
| 3 | Atrium Therapeutics Inc COM | $8.6M | 641.5K | 5.7% | ▲New New position | |
| 4 | AI Financial Corp COM | $7.4M | 12.70M | 4.9% | ▲+0.7% Added · +90K sh | |
| 5 | Playboy Inc COM | $7.0M | 5.76M | 4.6% | ▲+32% Added · +1.4M sh | |
| 6 | Bitgo Holdings Inc-CL A COM SHS CL A | $6.8M | 1.31M | 4.5% | ▲New New position | |
| 7 | Ishares 0-3 Month Treasury B SHS | $4.8M | 47.2K | 3.1% | ▲New New position | |
| 8 | Vizsla Silver Corp COM NEW | $2.8M | 848.2K | 1.8% | ▲New New position | |
| 9 | Burning Rock Biotech Ltd-ADR SPONSORED ADS | $1.8M | 212.0K | 1.2% | ▼−25% Reduced · −70K sh | |
| 10 | Procap Acquisition Corp - A SHS CL A | $1.7M | 160.7K | 1.1% | ▲+5.4% Added · +8K sh | |
| 11 | Perceptive Capital Solutions CL A ORD SHS | $1.1M | 97.3K | 0.7% | ▼−16% Reduced · −19K sh | |
| 12 | First Tracks Biotherapeutics ORD SHS | $711K | 35.3K | 0.5% | ▲New New position | |
| 13 | Usbc Inc. COM NEW | $174K | 555.3K | 0.1% | —Held | |
| 14 | Procap Acquisition Corp *W EXP 05/16/203 | $33K | 102.7K | 0.0% | ▲New New position |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1483234/holdings"
Use Arkolith to show CRCM LP's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 18, 2026 | 14 | $152.2M | 13F-HR/A |
| Q1 2026 | Mar 31, 2026 | May 13, 2026 | 16 | $141.2M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 13, 2026 | 30 | $296.0M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 48 | $345.7M | 13F-HR/A |
| Q2 2025 | Jun 30, 2025 | Aug 13, 2025 | 37 | $336.6M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 | 23 | $245.3M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 7, 2025 | 20 | $245.9M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.